Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 4/20 | 1.00 |
| ▸ | CNR2 | P34972 | 4/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 3/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 2/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 2/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 1.00 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 1.00 |
| ▸ | TRPV3 | Q8NET8 | 2/20 | 1.00 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 1.00 |
| ▸ | TRPV2 | Q9Y5S1 | 2/20 | 1.00 |
| ▸ | LDHA | P00338 | 1/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.64 |
| ▸ | HRH1 | P35367 | 1/20 | 0.64 |
| ▸ | APP | P05067 | 2/20 | 0.62 |
| ▸ | PPARG | P37231 | 2/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cannabichromene SCHEMBL29939768 | 1.00 | CNR1 (1.00) | CNR1CNR2SLC6A2TRPV1TRPA1 | |
| Cannabichromene SCHEMBL22095415 | 1.00 | CNR1 (1.00) | CNR1CNR2SLC6A2TRPV1TRPA1 | |
| Cannabichromene SCHEMBL22095394 | 1.00 | CNR1 (1.00) | CNR1CNR2SLC6A2TRPV1TRPA1 | |
| SCHEMBL25867685 | 0.99 | CNR1 (0.98) | CNR1CNR2SLC6A2TRPV1TRPA1 | |
| SCHEMBL29647739 | 0.99 | CNR1 (0.98) | CNR1CNR2SLC6A2TRPV1TRPA1 | |
| SCHEMBL23765284 | 0.97 | SLC6A2 (0.93) | CNR1CNR2SLC6A2TRPV1TRPA1 | |
| SCHEMBL22069544 | 0.94 | SLC6A2 (0.88) | CNR1CNR2SLC6A2TRPV1TRPA1 | |
| SCHEMBL22069541 | 0.94 | SLC6A2 (0.88) | CNR1CNR2SLC6A2TRPV1TRPA1 | |
| SCHEMBL31545669 | 0.94 | SLC6A2 (0.88) | CNR1CNR2SLC6A2TRPV1TRPA1 | |
| SCHEMBL31545773 | 0.94 | SLC6A2 (0.88) | CNR1CNR2SLC6A2TRPV1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 12885 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144805-A1 | CANNABIDIOL COMPOSITIONS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE AND NEUROLOGICAL DISORDERS | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (GB) | 2026-05-28 | — | — | US | claimed |
| EP-4412609-B1 | ALKOXYLATION OF CANNABIDIOL & OTHER CANNABINOIDS | INDORAMA VENTURES OXIDES LLC (US) | 2026-05-27 | — | — | EP | claimed |
| US-12636251-B1 | Glycoside-containing aqueous formulations having a lipophilic active component | Doane Technology Group LLC (US) | 2026-05-26 | — | — | US | claimed |
| US-12636294-B2 | Compositions and methods for the treatment or prevention of traumatic brain injury | Incannex Healthcare Limited (AU) | 2026-05-26 | — | — | US | claimed |
| US-20260137705-A1 | NOVEL CANNABINOID NANOPARTICLE COMPOSITIONS FOR THERAPEUTIC APPLICATIONS IN VETERINARY MEDICINE | Chou2 Pharma LLC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4041390-B1 | CANNABIDIOL AND ISOFLURANE FOR THE TREATMENT OR PREVENTION OF TRAUMATIC BRAIN INJURY | INCANNEX HEALTHCARE LTD (AU) | 2026-05-20 | — | — | EP | claimed |
| US-12629383-B2 | Cannabinoid compositions with high solubility and bioavailability | PISAK MEHMET NEVZAT (TR) | 2026-05-19 | — | — | US | claimed |
| EP-4739284-A1 | AN ADHESIVE ORAL DISC FOR SUSTAINED RELEASE OF CANNABINOIDS | Fertin Pharma A/S (DK) | 2026-05-13 | — | — | EP | claimed |
| EP-4740961-A2 | CANNABINOID PRODUCT FOR IMPROVING MUSCULOSKELETAL HEALTH | Lonza Greenwood LLC (US) | 2026-05-13 | — | — | EP | claimed |
| US-12622920-B2 | Process for creating a cannabinoid pico-emulsion with antibiotic properties and the resulting pico-emulsion | PICO IP, LLC (US) | 2026-05-12 | — | — | US | claimed |
| US-20030171372-A1 | Antiviral methods and compounds | IMMUGEN PHARMACEUTICALS, INC. (US) | 2003-09-11 | — | — | US | claimed |
| WO-2003037306-A2 | INHALATION OF VAPOUR OF THERAPEUTICAL SUBSTANCES, LIKE E.G. CANNABIS EXTRACT | GW PHARMA LIMITED (GB) | 2003-05-08 | — | — | WO | claimed |
| US-6541510-B2 | Cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus, especially HIV. | IMMUGEN PHARMACEUTICALS, INC. | 2003-04-01 | — | — | US | claimed |
| US-20030021752-A1 | Pharmaceutical formulations | GW PHARMA LIMITED (GB) | 2003-01-30 | — | — | US | claimed |
| WO-2002064109-A2 | MUCOADHESIVE PHARMACEUTICAL FORMULATIONS | GW PHARMA LIMITED (GB) | 2002-08-22 | — | — | WO | claimed |
| US-6403126-B1 | Cannabinoid extraction method | WEBSAR INNOVATIONS INC. (CA) | 2002-06-11 | — | — | US | claimed |
| US-20020068738-A1 | Antiviral methods and compounds | IMMUGEN PHARMACEUTICALS, INC. | 2002-06-06 | — | — | US | claimed |
| WO-2002026728-A2 | ANTIVIRAL METHODS AND COMPOUNDS | IMMUGEN PHARMACEUTICALS, INC. (US) | 2002-04-04 | — | — | WO | claimed |
| US-4837228-A | HYPOTERMIC AGENTS | THE UNIVERSITY OF MISSISSIPPI (US) | 1989-06-06 | — | — | US | claimed |
| US-4315862-A | FROM CITRAL AND A RESORCINOL PERIVATIVE | THE UNIVERSITY OF MISSISSIPPI (US) | 1982-02-16 | — | — | US | claimed |